Literature DB >> 20368826

Preoperative concurrent chemoradiotherapy with oral fluoropyrimidine in locally advanced rectal cancer: how good is good enough?

Hyun Cheol Chung.   

Abstract

Entities:  

Year:  2004        PMID： 20368826      PMCID： PMC2843879          DOI： 10.4143/crt.2004.36.6.341

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN： 1598-2998            Impact factor:   4.679


× No keyword cloud information.
  10 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.

Authors:  M Mohiuddin; W F Regine; W J John; P F Hagihara; P C McGrath; D E Kenady; G Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-03-01       Impact factor: 7.038

3.  Prospective phase II study of preoperative chemoradiation with capecitabine in locally advanced rectal cancer.

Authors:  Jin-hong Park; Jong Hoon Kim; Seung Do Ahn; Sang-wook Lee; Seong Soo Shin; Jin Cheon Kim; Chang Sik Yu; Hee Cheol Kim; Yoon-Koo Kang; Tae Won Kim; Heung Moon Chang; Min Hee Ryu; Eun Kyung Choi
Journal:  Cancer Res Treat       Date:  2004-12-31       Impact factor: 4.679

4.  Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.

Authors:  N A Janjan; J Abbruzzese; R Pazdur; V S Khoo; K Cleary; R Dubrow; J Ajani; T A Rich; M S Goswitz; P A Evetts; P K Allen; P M Lynch; J M Skibber
Journal:  Radiother Oncol       Date:  1999-05       Impact factor: 6.280

5.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

6.  Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer.

Authors:  Jürgen Dunst; Thomas Reese; Thomas Sutter; Helmut Zühlke; Axel Hinke; Katrin Kölling-Schlebusch; Stefan Frings
Journal:  J Clin Oncol       Date:  2002-10-01       Impact factor: 44.544

7.  Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma.

Authors:  S Meterissian; J Skibber; T Rich; L Roubein; J Ajani; K Cleary; D M Ota
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

8.  Preoperative infusional chemoradiation therapy for stage T3 rectal cancer.

Authors:  T A Rich; J M Skibber; J A Ajani; D J Buchholz; K R Cleary; R A Dubrow; B Levin; P M Lynch; S H Meterissian; L D Roubein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-15       Impact factor: 7.038

9.  Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.

Authors:  Jean-Pierre Gérard; Olivier Chapet; Chantal Nemoz; Pascale Romestaing; Françoise Mornex; Régis Coquard; Nicolas Barbet; Dan Atlan; Patrice Adeleine; Gilles Freyer
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

10.  Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.

Authors:  Ana Escribano Uzcudun; Jaime Feliu Batlle; Jesús Calvillo Velasco; María Elena Sánchez Santos; Javier De Castro Carpeño; Antonio García Grande; Alberto Mata Juberías; Elena Hernández Piñeiro; Lara Miralles Olivar; Alfredo García García
Journal:  Dis Colon Rectum       Date:  2002-10       Impact factor: 4.585
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.